Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Scandinavian Biogas has finalized the acquisition of Ekdalens Biotransporter AB

Scandinavian Biogas Fuels International AB (publ) (“Scandinavian Biogas” or the “Company”), a leading producer of biogas in the Nordics, today announces it has finalized the acquisition of Ekdalens Biotransport AB (“Ekdalens”), which was published by press release on 30 November 2020. Scandinavian Biogas has today completed the acquisition of all shares in Ekdalens. The acquisition is part of Scandinavian Biogas’s strategy to achieve greater integration across the entire value chain, from organic waste to produced biogas and bio-fertiliser, and the capacity to offer comprehensive

Latour acquires ELSYS

Investment AB Latour (publ) has, through its subsidiary Bemsiq AB, signed an agreement to acquire 70 per cent of the shares of Elektroniksystem i Umeå AB ("Elsys"). The founders remain as part-owners with 30 per cent of the shares. Elsys is an internationally leading manufacturer and seller of LoRaWAN® sensors for applications for smart buildings and cities. The company was founded in 2005 and has 7 employees with head office and manufacturing in Umeå, Sweden. Net sales in 2019 was SEK 29 million and is expected to amount to SEK 45 million in 2020. "We have followed Elsys for a long

Saga Pure ASA: Private placement in Bergen Carbon Solutions approved and option agreement signed

(Oslo, 18 December 2020) Reference is made to the stock exchange release as of 11 December 2020 regarding Saga Pure ASA’s (Saga, OSE: SAGA) subscription of NOK 30 million in a gross NOK 40 million private placement of new shares (the “Private Placement”) in Bergen Carbon Solutions AS (BCS), corresponding to an ownership of 21.4% in BCS. On 18 December the Extraordinary General Meeting of BCS approved the oversubscribed Private Placement, whereof Saga has been allocated shares for the full subscription amount of NOK 30 million, corresponding to an ownership of 21.4%.  Payment of the

Stora Enso divests non-core forest holdings in southern Sweden

STORA ENSO OYJ INVESTOR NEWS 18 December 2020 at 15.15 EETAs part of its forest land optimisation, Stora Enso has signed an agreement to divest forest assets located in southern Sweden to the forestry fund Silvestica Green Forest AB. The total area of forest land in the transaction is approximately 5 200 hectares. The selling price is approximately SEK 940 million (EUR 90 million).The transaction is in line with Stora Enso’s policy of divesting non-core assets. The forest areas are located geographically far away from Stora Enso’s other forest lands, which limits the scale benefits. The

HANZA builds new production facility in Estonia

HANZA Holding AB (publ) expands its capacity for regional manufacturing in the Baltics and investsapprox. SEK 80 million in a new production facility of just over 12,000 m2 in Tartu, Estonia."We are now building a tailor-made factory for complex assembly, which creates capacity for continued growth and supports our solution for sustainable manufacturing," says HANZA's CEO Erik Stenfors. HANZA's new plant will be built directly adjacent to HANZA's production plant for sheet metal production. The total investment amounts to approximately SEK 80 million and is financed with a combination

Smoltek extends license agreement for evaluation of the company’s CNF-MIM-technology

Smoltek announces that the agreement signed with a leading capacitor manufacturer for technical and commercial evaluation of the company’s CNF-MIM technology has been further extended, to December 31. At the same time, the parties have initiated a concrete dialogue on a possible continuation of the collaboration, with a decision to be expected during the first quarter of 2021. This press release is an English version of the previously published Swedish version, which has interpretative preference.This spring, Smoltek announced two separate license agreements for technical and commercial

Adapteo announces changes to its financial calendar and dual listing timeline

Adapteo Plc Regulatory Press release 18 December at 2:00 p.m. CET As announced on 9 December, due to Adapteo’s acquisition of Stord Innkvartering and the related financing, as well as the consolidation of the October acquisition of the Dutch Cabin Group, Adapteo will postpone the publication of its Financial Statements Release 2020 to 18 February 2021. It was previously scheduled to be published on 5 February 2021. For these reasons Adapteo has also decided to postpone its listing on Nasdaq Helsinki to Q2 2021. Postponing the listing on Nasdaq Helsinki will enable Adapteo to focus on

Kemira’s Board of Directors resolved on the share allocation of the commencing performance period for the long-term incentive plan

Kemira Oyj, Other information disclosed according to the rules of the Exchange, December 18, 2020 at 3.00 pm (EET)Kemira’s Board of Directors resolved on the share allocation of the commencing performance period for the long-term incentive plan Kemira has a long-term share incentive plan for key employees, which includes altogether two one-year performance periods: years 2019 and 2020 and three three-year performance periods: years 2019-2021, 2020-2022 and 2021-2023 decided by the Board of Directors of Kemira Oyj in December 2018.The Board of Directors of Kemira Oyj has decided the

MTG completes the acquisition of Hutch Games Ltd.

STOCKHOLM, December 18th, 2020 – Modern Times Group MTG AB (publ.) (“MTG”) has completed the previously announced acquisition of 100% of Hutch Games Ltd. (“Hutch”), a leading developer and publisher of free-to-play mobile games focused on the racing genre in the midcore segment, for an up-front consideration amount of USD 275 million (on a cash and debt free basis) and earn-out payments at an expected value of USD 100 million in aggregate.MTG’s acquisition of Hutch was announced December 8, 2020 

Etrion Corporation to redeem EUR 40 million of outstanding Corporate Bonds ISIN N00010823958 – Etrion Corporation Senior Secured Bond Issue 2018/2021

December 18, 2020, Geneva, Switzerland Nordic Trustee AS acts as Bond Trustee for the Bondholders in the above-mentioned bond issue with Etrion Corporation as Issuer and Solar Resources Holding Sàrl as Guarantor. All capitalized terms used herein shall have the meaning as assigned to them in the Bond Terms dated 13 June 2018 unless the contrary indication appears. The Issuer has in a letter to the Bond Trustee on 18 December 2020 notified that the Issuer will exercise the Call Option to redeem all of the Outstanding Bonds as per the Call Option Repayment Date (as defined below)

Settlement between Uponor Innovation AB and Nexam Chemical AB

Nexam Chemical AB and Uponor Innovation AB have entered into a settlement agreement to resolve a litigation concerning patent rights for Polyethylene Pipe applications. In the settlement Nexam Chemical AB will withdraw the litigation against Uponor Innovation AB for the Patent including products based on Nexam materials (PCT/EP2016/058812). In the same settlement Uponor Innovation AB has issued a licence for Nexam Chemical Holding AB to sell products under the same patent with a licencing fee. Uponor will under this agreement exclusively buy the active component from Nexam Chemical AB.With

Sensible 4's self-driving vehicle software is tested in Finnish Lapland

The rapidly growing and internationalising Finnish company specialising in self-driving software, Sensible 4, uses an autonomous test vehicle to collect information about the different winter traffic environments and situations in Fell Lapland.On Monday, December 14th, Sensible 4, which develops autonomous self-driving software, announced its collaboration with Toyota Motor Europe and shall test its technology in Lapland with a vehicle it has automated. The testing period aims to collect measurement data in adverse weather conditions and test the newest functions of the autonomous software

CONDITIONALITIES FOR PAYMENT OF INSTRUCTION FEES IN CONSENT SOLICITATION FOR KONECRANES PLC’S NOTES DUE 2022 HAVE BEEN FULLFILLED

KONECRANES PLC STOCK EXCHANGE RELEASE 18 DECEMBER 2020 AT 14:45 EET NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW CONDITIONALITIES FOR PAYMENT OF INSTRUCTION FEES IN CONSENT SOLICITATION FOR KONECRANES PLC’S NOTES DUE 2022 HAVE BEEN FULLFILLED As announced earlier today by Konecranes Plc (“Konecranes”) and Cargotec Corporation (“Cargotec”), the extraordinary general meetings of Konecranes and Cargotec have approved the merger of Konecranes into Cargotec in accordance with the merger plan

Herantis Pharma Plc: 2,162,163 new shares registered with the trade register

Company release, 18 December 2020 at 2:45 p.m. Eastern European Time THE INFORMATION CONTAINED IN THIS RELEASE IS NOT FOR PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR IN ANY OTHER JURISDICTION IN WHICH PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Herantis Pharma Plc ("Herantis" or the "Company"), an innovative drug development company pioneering new disease modifying and regenerative biologic and gene therapies, announced on 17 December 2020 the result of the offering of new

Dr. Rickard Brånemark and Magnus Niska to Appear on TV4 Nyhetsmorgon, Saturday, December 19[th], 09:20.

On Saturday morning, Dr. Rickard Brånemark, founder of Integrum AB, and Magnus Niska, the first patient in the world treated with Integrum’s revolutionary e-OPRA[TM] Implant System, will be interviewed on the very popular TV show, Nyhetsmorgon, on channel 4 in Sweden.During the interview, Dr. Brånemark will discuss this unique and revolutionary treatment, which has its foundation in Integrum’s OPRA[TM] Implant System; technology which builds upon Rickard Brånemark’s research within osseointegrated prostheses, and offers amputee patients the unique opportunity to reclaim an active lifestyle,

Ahlstrom-Munksjö’s financial information in 2021 and change in the company’s reporting language

AHLSTROM-MUNKSJÖ OYJ, STOCK EXCHANGE RELEASE December 18, 2020 at 14:30 EET Ahlstrom-Munksjö plans to publish financial reports in 2021 as follows: · Financial statements release 2020: February 10, 2021 · Interim report January-March 2021: April 27, 2021 · Half-year report January-June 2021: July 23, 2021 · Interim report January-September 2021: October 27, 2021 The annual report including financial statements for 2020 and the report of operations will be available on the company’s web site at www.ahlstrom-munksjo.com during the week starting on February 22, 2021.

Altia Plc: Notification pursuant to Chapter 9, section 5 of the Securities Markets Act

Altia Plc  Stock Exchange Release  18 December 2020 at 2:00 pm EET Altia Plc: Notification pursuant to Chapter 9, section 5 of the Securities Markets Act Altia Plc has on 18 December 2020 received the following notification pursuant to Chapter 9, section 5 of the Securities Markets Act ("SMA") regarding an ownership arrangement following which the shareholding of Valtion kehitysyhtiö Vake Oy (State’s Business Development Company) falls below and the shareholding of the State of Finland exceeds a threshold according to Chapter 9, section 5 of the SMA. Valtion kehitysyhtiö Vake Oy

Resurs confirms its strength by selling non-performing loans to a leading international investor

Resurs Bank, a wholly owned subsidiary of Resurs Holding, has entered into an agreement with a leading international investor in non-performing loans to sell parts of Resurs Bank’s non-performing loans for a gross carrying amount of just over SEK 500 million. The sale will have a positive impact on Resurs Bank’s capital requirements and liquidity and a neutral effect on earnings.The sale is expected to be completed at the end of the fourth quarter of 2020 and is in line with the strategy for the management of non-performing loans that Resurs Bank has followed since the autumn of 2018. The

Resurs confirms its strength by selling non-performing loans to a leading international investor

Resurs Bank has entered into an agreement with a leading international investor in non-performing loans to sell parts of Resurs Bank’s non-performing loans for a gross carrying amount of just over SEK 500 million. The sale will have a positive impact on Resurs Bank’s capital requirements and liquidity and a neutral effect on earnings.The sale is expected to be completed at the end of the fourth quarter of 2020 and is in line with the strategy for the management of non-performing loans that Resurs Bank has followed since the autumn of 2018. The strategy aims to continuously sell non-

Restated figures according to new reporting structure

As a consequence of a reorganization, BillerudKorsnäs changed its reporting structure as of 1 October 2020. To enable comparisons in coming financial reports, BillerudKorsnäs presents recalculated figures are presented for all quarters 2019 and the first three quarters 2020. BillerudKorsnäs’ financial performance is reviewed in three operating segments: Product area Board, Product area Paper as well as Solutions and other.  •    Product area Board includes sales and costs related to liquid packaging board, cartonboard and containerboard.  •    Product area Paper includes sales and

Klaria announces first dose of its Sumatriptan Alginate Film (KL-00119)

Klaria Pharma Holding AB announced today that the first group of subjects received their first dose in the company’s pivotal Bioequivalence Study of Sumatriptan Alginate Film. The dosing of all 12 subjects in the first group took place on Tuesday, December 15[th].A total of 60 subjects will be dosed in the study.  The study has a cross-over design, where all subjects will receive both Sumatriptan Alginate Film as well as the comparator product.   The comparator product used in the study has been approved by both the European regulatory authority, EMA, as well as the US regulatory authority,

Actiste® Mini receives market approval in the Kingdom of Saudi Arabia

Brighter AB (publ) is proud to announce that the diabetes management device Actiste® Mini has received market approval from the Saudi Food and Drug Authority (SFDA). Actiste® Mini is a smart and user-friendly blood glucose meter with global out-of-the-box internet connectivity through eSIM, aiming to support successful diabetes management and monitoring. The new device, based on the original Actiste® hardware technology platform, will be a key component in a new service currently being developed by Brighter. In November 2020, Brighter announced that the company's first product,

Balcos advances to Nasdaq Stockholm’s Mid Cap-segment

Balco Group AB (publ) (BALCO) advances to Nasdaq Stockholm’s Mid Cap segment on 4th  January 2021.The movement from the Small Cap segment takes place as a result of the Nasdaq annual review of its Nordic market capitalization (market cap) segments. The Mid Cap segment includes companies with a market value between 150 MEUR and 1,000 MEUR.   For more information, please contact:Michael Grindborn, CFO and Head of IR, +46 70 670 18 48, michael.grindborn@balco.se

Veidekke ASA: To build the Fosslia Care Centre in Stjørdal

Veidekke has today signed a contract with Stjørdal Municipality to construct a new care centre in Fosslia in Stjørdal. The centre will contain 76 residential units as well as a service building with day centre, shop/kiosk and hair/foot care lounge. The commission is a design and build contract with a value of just over NOK 250 million, excluding VAT.- This is a long-awaited project of great importance for the municipality's inhabitants and for the care sector. We are proud that we won the competition for the commission, being able to build such a modern and specially adapted dementia

There are no items matching the current filter
There are no more items matching the current filter
Back to top